GPX4 and glioblastoma: With systemic administration, synergistic ferroptosis therapy of GBM is achieved by the combined triple actions of the disintegration of DHODH and the GPX4 ferroptosis defense axis with Fe3O4 nanoparticle-mediated Fe2+ release.